688189 南新製藥
按盤價 
8.100 -0.100 (-1.220%) | 2025/09 - 九個月 人民幣(K¥) | 與去年末期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | |
非流動資產 | ||||||
| 長期股權投資 | 0 | -- | 0 | 0 | 0 | 0 |
| 投資性房地產 | 0 | -- | 0 | 0 | 0 | 0 |
| 固定資產 | 149,880 | -8.36% | 163,557 | 184,895 | 200,731 | 223,585 |
| 在建工程 | 5,525 | 1,465.16% | 353 | 573 | 240 | 1,275 |
| 無形資產 | 130,895 | -8.55% | 143,135 | 124,284 | 138,006 | 158,413 |
| 商譽 | 0 | -- | 0 | 10,845 | 10,845 | 13,569 |
| 其他非流動資產 | 173,674 | 26.73% | 137,043 | 126,928 | 108,614 | 120,846 |
| 459,974 | 3.58% | 444,089 | 447,525 | 458,436 | 517,689 | |
流動資產 | ||||||
| 貨幣資金 | 427,810 | -12.74% | 490,270 | 665,761 | 713,472 | 730,668 |
| 應收賬款 | 62,587 | -68.00% | 195,598 | 520,669 | 728,193 | 590,813 |
| 存貨 | 47,548 | -22.27% | 61,167 | 30,366 | 27,015 | 61,425 |
| 其他流動資產 | 35,970 | 14.87% | 31,315 | 55,063 | 27,492 | 230,275 |
| 573,915 | -26.27% | 778,350 | 1,271,858 | 1,496,172 | 1,613,181 | |
流動負債 | ||||||
| 短期借款 | 148,199 | -32.08% | 218,187 | 322,950 | 488,733 | 385,437 |
| 應付票據 | 0 | -- | 0 | 0 | 0 | 80,000 |
| 應付帳款 | 16,754 | -57.68% | 39,591 | 39,548 | 37,496 | 76,467 |
| 其他流動負債 | 64,705 | -21.16% | 82,075 | 65,538 | 122,127 | 132,766 |
| 229,659 | -32.42% | 339,853 | 428,035 | 648,355 | 674,671 | |
| 流動資產淨值 | 344,256 | -21.49% | 438,497 | 843,822 | 847,817 | 938,510 |
| 資產總額減流動負債 | 804,230 | -8.88% | 882,586 | 1,291,348 | 1,306,253 | 1,456,199 |
非流動負債 | ||||||
| 長期借款 | 0 | -- | 0 | 0 | 0 | 50,846 |
| 應付債券 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他非流動負債 | 3,669 | -14.28% | 4,280 | 5,768 | 9,881 | 11,370 |
| 3,669 | -14.28% | 4,280 | 5,768 | 9,881 | 62,216 | |
總權益 | ||||||
| 實收股本 | 274,400 | 0.00% | 274,400 | 274,400 | 196,000 | 140,000 |
| 儲備項目 | 591,590 | -10.66% | 662,192 | 1,029,096 | 1,118,365 | 1,253,197 |
| 股東權益 | 865,990 | -7.54% | 936,592 | 1,303,496 | 1,314,365 | 1,393,197 |
| 非控股權益 | (65,430) | 12.26% | (58,286) | (17,916) | (17,993) | 786 |
| 備註： | 即時報價更新時間為 23/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
